Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
HYAL1 encodes a lysosomal hyaluronidase. Additionally we are shipping HYAL1 Kits (19) and HYAL1 Proteins (17) and many more products for this protein.
Showing 10 out of 115 products:
Human Polyclonal HYAL1 Primary Antibody for EIA, IHC (p) - ABIN952807
Lanktree, Johansen, Anand, Davis, Miller, Yusuf, Hegele, ,: Genetic variation in hyaluronan metabolism loci is associated with plasma plasminogen activator inhibitor-1 concentration. in Blood 2010
Show all 3 references for ABIN952807
Human Polyclonal HYAL1 Primary Antibody for WB - ABIN516763
Papakonstantinou, Kouri, Karakiulakis, Klagas, Eickelberg: Increased hyaluronic acid content in idiopathic pulmonary arterial hypertension. in The European respiratory journal 2008
Mouse (Murine) Polyclonal HYAL1 Primary Antibody for ELISA, WB - ABIN334422
Daginakatte, Gutmann: Neurofibromatosis-1 (Nf1) heterozygous brain microglia elaborate paracrine factors that promote Nf1-deficient astrocyte and glioma growth. in Human molecular genetics 2007
Cow (Bovine) Polyclonal HYAL1 Primary Antibody for IHC, WB - ABIN2784342
Poola, Abraham, Marshalleck, Yue, Lokeshwar, Bonney, Dewitty: Molecular risk assessment for breast cancer development in patients with ductal hyperplasias. in Clinical cancer research : an official journal of the American Association for Cancer Research 2008
The receiver-operating characteristic curve analyses demonstrated that each one had good sensitivity and specificity for distinguishing BC patients from non-BC ones (HYAL1, miR (show MLXIP Antibodies)-210, miR (show MLXIP Antibodies)-96, lncRNA-UCA1, 91.5 and ).
Study showed that reduced HYAL1 expression was associated with endometrial carcinoma aggressiveness, which further supported the role of hyaluronan degradation in cancer progression.
Results demonstrated that HYAL1 was C-mannosylated and suggest the possible role of C-mannosylation for secretion and enzymatic activity of HYAL1.
Hyaluronan (HA) interacting proteins RHAMM (show HMMR Antibodies) and hyaluronidase (show HAase Antibodies) impact prostate cancer cell behavior and invadopodia formation in 3D HA-based hydrogels.
In contrast to the previously described MPS IX patient, our three patients display a phenotype limited to the joints, suggesting that this is the primary manifestation of HYAL1 deficiency.
Upregulation of HYAL1 expression in breast cancer promoted tumor cell proliferation, migration, invasion and angiogenesis.
This is the first report showing high HYAL-1 levels in epithelial ovarian cancer.
HYAL-1 and HAS1 (show HAS1 Antibodies) expression predicted BCa (show BLNK Antibodies) metastasis, and HYAL-1 expression also predicted disease-specific survival.
HYAL1 overexpression is correlated with the malignant behavior of breast cancer.
Hyaluronan synthases (HAS1 (show HAS1 Antibodies)-3) and hyaluronidases (HYAL1-2) in the accumulation of hyaluronan in endometrioid endometrial carcinoma
results are consistent with a role for hyaluronan and hyaluronoglucosaminidase 1 and 2 in the development of the microscopic folds of the pig placenta during gestation
the porcine hyaluronidase (show HAase Antibodies) cluster consisting of genes HYAL1, HYAL2 (show HYAL2 Antibodies) and HYAL3 (show HYAL3 Antibodies) was characterized
This study focuses on the investigation of the digestibility of glycosaminoglycans with different degrees of sulfation by bovine testicular hyaluronidase (show HAase Antibodies).
HYAL1 is necessary for the breakdown of intracellular HA in the cortex, whereas HYAL2 (show HYAL2 Antibodies) is essential for the degradation of extracellular HA in all kidney regions
The activity of the processed form of Hyal-1 was largely underestimated.
The knockdown of Hyal-1 results in an 80% decrease of total acid hyaluronidase (show HAase Antibodies) activity in the mouse liver, confirming that Hyal-1 is a key actor of hyaluronic acid catabolism in this organ.
Chondroitin sulfate is a crucial determinant for skeletal muscle development/regeneration and improvement of muscular dystrophies through HYAL1
both HYAL1 and beta-hexosaminidase (show HEXA Antibodies) cleave chondroitin sulfate, but it is a preferred substrate for beta-hexosaminidase (show HEXA Antibodies). These studies provide in vivo evidence to support and extend existing knowledge of GAG breakdown.
Data show that Hyal-1, but not Hyal-3 (show HYAL3 Antibodies),is an ovarian regulator factor for follicle development, and show an interrelationship between this enzyme and the follistatin (show FST Antibodies)/activin (show Actbeta Antibodies)/Smad3 (show SMAD3 Antibodies) pathway.
Endothelial surface layer degradation by chronic hyaluronidase (show HAase Antibodies) infusion induces proteinuria in apolipoprotein E (show APOE Antibodies)-deficient mice
Characterization of the murine hyaluronidase (show HAase Antibodies) gene region reveals complex organization and cotranscription of Hyal1 with downstream genes, Fus2 (show NAT6 Antibodies) and Hyal3 (show HYAL3 Antibodies).
Hyal1 null mice had evidence of osteoarthritis with a loss of proteoglycans at early ages.
Hyaluronidase (show HAase Antibodies) induces ovarian granulosa cell apoptosis and is involved in follicular atresia.
This gene encodes a lysosomal hyaluronidase. Hyaluronidases intracellularly degrade hyaluronan, one of the major glycosaminoglycans of the extracellular matrix. Hyaluronan is thought to be involved in cell proliferation, migration and differentiation. This enzyme is active at an acidic pH and is the major hyaluronidase in plasma. Mutations in this gene are associated with mucopolysaccharidosis type IX, or hyaluronidase deficiency. The gene is one of several related genes in a region of chromosome 3p21.3 associated with tumor suppression. Multiple transcript variants encoding different isoforms have been found for this gene.
, lung carcinoma protein 1
, plasma hyaluronidase
, tumor suppressor LUCA-1
, hyaluronidase 1